Celltrion
068270.KS
#858
Rank
S$34.91 B
Marketcap
S$159.59
Share price
-0.44%
Change (1 day)
-3.89%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): S$2.46

According to Celltrion 's latest financial reports the company's current EPS (TTM) is S$2.43. In 2023 the company made an earnings per share (EPS) of S$3.55 a decrease over its 2022 EPS that were of S$3.63.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$2.46
2023S$3.55-2.08%
2022S$3.63-11.72%
2021S$4.112.03%
2020S$4.0382.8%
2019S$2.2018.31%
2018S$1.86-36.33%
2017S$2.92161.25%
2016S$1.122.86%
2015S$1.0917.84%
2014S$0.925.87%
2013S$0.87-70.85%
2012S$2.99134.09%
2011S$1.2843.59%
2010S$0.8974.49%
2009S$0.51317.8%
2008S$0.12-71.7%
2007S$0.43